PCI Biotech Holding ASA operates in the Commercial physical research sector.
In addition to historical fundamental analyses, the complete report available to purchase compares PCI Biotech Holding ASA with three other
miscellaneous service companies in Europe:
sales of 4.19 million Polish New Zlotys [US$1.02 million]
(920,000.00 Euro [US$978,723.60 ]
of which 100%
was Pharmaceutical Products), and
based in Sweden
(13.63 million Swedish Kronor [US$1.53 million]
PCI Biotech Holding ASA reported sales of NOK 10.47 million (US$1.23 million)
December of 2015.
increase of 43.4%
versus 2014, when the company's sales were NOK 7.30 million.
The sales level in 2015 was fairly close to the level five years ago: in 2010, PCI Biotech Holding ASA had sales
of NOK 10.44 million.